COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020

Grand Hôpital de Charleroi

Status: Completed

Conditions: Covid19

Treatments: Diagnostic Test: Serological tests for SARS Cov-2

Study type: Interventional

Funder types: Other

Identifiers

NCT04723290

SERO-SARS-CoV-2 GHdC

Details and patient eligibility

About

The management of the Grand Hôpital de Charleroi hospital authorized the performance of a serology for each member of the establishment's staff in order to better characterize the proportion of its employees who have already been in contact with the SARS CoV-2 virus for organizational and evaluation purposes symptoms.

Full description

At the start of the SARS-CoV-2 pandemic, several workers had symptoms compatible with COVID-19 at a time when PCR (smear) testing was only allowed for hospitalized people. In addition, the PCR test has a fairly low sensitivity. In this context, serology can make it possible to determine whether the symptoms are indeed linked to exposure to SARS-CoV-2.

As a hospital, and in order to prepare for a possible second epidemic wave, it is also useful to know the proportion of staff members who have already been in contact with the virus for organizational purposes and symptom assessment.

.

Enrollment: 2,817 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Be a member of the staff of the Grand Hôpital de Charleroi who wishes to participate in order to know their immunity related to SARS CoV-2 after the first wave of pandemic.

Exclusion criteria

• Not be part of the staff of the Grand Hôpital de Charleroi.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2,817 participants in 1 patient group

Serological tests

Experimental group

Description:

All staff at GHdC who want to know their level of antibodies against SARS CoV-2

Treatment:

Diagnostic Test: Serological tests for SARS Cov-2